Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Hematolymphoid Lesions of the Sinonasal Tract.

Kreisel FH.

Head Neck Pathol. 2016 Mar;10(1):109-17. doi: 10.1007/s12105-016-0698-5. Epub 2016 Feb 1.

PMID:
26830397
2.

De novo CD5+ diffuse large B-cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort.

Alinari L, Gru A, Quinion C, Huang Y, Lozanski A, Lozanski G, Poston J, Venkataraman G, Oak E, Kreisel F, Park SI, Matthews S, Abramson JS, Iris Lim H, Martin P, Cohen JB, Evens A, Al-Mansour Z, Singavi A, Fenske TS, Blum KA.

Am J Hematol. 2016 Jun;91(4):395-9. doi: 10.1002/ajh.24299.

3.

Outcomes with R-CEOP for R-CHOP-ineligible patients with diffuse large B-cell lymphoma are highly dependent on cell of origin defined by Hans criteria.

Rashidi A, Oak E, Carson KR, Wagner-Johnston ND, Kreisel F, Bartlett NL.

Leuk Lymphoma. 2016 May;57(5):1191-3. doi: 10.3109/10428194.2015.1096356. Epub 2015 Oct 20. No abstract available.

PMID:
26397936
4.

Expression of TIA1 and PAX5 in Classical Hodgkin Lymphoma at Initial Diagnosis May Predict Clinical Outcome.

Nguyen TT, Frater JL, Klein J, Chen L, Bartlett NL, Foyil KV, Kreisel FH.

Appl Immunohistochem Mol Morphol. 2015 Jun 5. [Epub ahead of print]

PMID:
26067141
5.
6.

T-cell prolymphocytic leukemia frequently shows cutaneous involvement and is associated with gains of MYC, loss of ATM, and TCL1A rearrangement.

Hsi AC, Robirds DH, Luo J, Kreisel FH, Frater JL, Nguyen TT.

Am J Surg Pathol. 2014 Nov;38(11):1468-83. doi: 10.1097/PAS.0000000000000272.

PMID:
25310835
7.

Mast cell leukemia with prolonged survival on PKC412/midostaurin.

Xu X, Kreisel FH, Frater JL, Hassan A.

Int J Clin Exp Pathol. 2014 May 15;7(6):3439-43. eCollection 2014.

8.

CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.

Klein JL, Nguyen TT, Bien-Willner GA, Chen L, Foyil KV, Bartlett NL, Duncavage EJ, Hassan A, Frater JL, Kreisel F.

Am J Clin Pathol. 2014 Mar;141(3):381-7. doi: 10.1309/AJCP61TLMXLSLJYS.

9.

Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers.

Wildes TM, Farrington L, Yeung C, Harrington AM, Foyil KV, Liu J, Kreisel F, Bartlett NL, Fenske TS.

Ther Adv Hematol. 2014 Feb;5(1):3-12. doi: 10.1177/2040620713514682. Review.

10.

Clinicopathologic features of adult T-cell leukemias/lymphomas at a North American tertiary care medical center: infrequent involvement of the central nervous system.

Hsi AC, Kreisel FH, Frater JL, Nguyen TT.

Am J Surg Pathol. 2014 Feb;38(2):245-56. doi: 10.1097/PAS.0000000000000109. Review.

PMID:
24418858
11.

Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma.

Pittman M, Treese S, Chen L, Frater JL, Nguyen TT, Hassan A, Kreisel F.

Arch Pathol Lab Med. 2013 Nov;137(11):1610-8. doi: 10.5858/arpa.2012-0313-OA.

PMID:
24168498
12.

Acute EBV infection masquerading as "In-situ Follicular Lymphoma": a pitfall in the differential diagnosis of this entity.

Gru AA, Kreisel F, Duncavage E, Nguyen TT, Hassan A, Frater JL.

Diagn Pathol. 2013 Jun 19;8:100. doi: 10.1186/1746-1596-8-100.

13.

Anaplastic large-cell lymphoma with aberrant expression of multiple cytokeratins masquerading as metastatic carcinoma of unknown primary.

Nguyen TT, Kreisel FH, Frater JL, Bartlett NL.

J Clin Oncol. 2013 Nov 20;31(33):e443-5. doi: 10.1200/JCO.2012.46.7910. Epub 2013 Jun 17. No abstract available.

14.

Assessment of cellular proliferation in tumors by PET using 18F-ISO-1.

Dehdashti F, Laforest R, Gao F, Shoghi KI, Aft RL, Nussenbaum B, Kreisel FH, Bartlett NL, Cashen A, Wagner-Johnston N, Mach RH.

J Nucl Med. 2013 Mar;54(3):350-7. doi: 10.2967/jnumed.112.111948. Epub 2013 Jan 28. Erratum in: J Nucl Med. 2013 May;54(5):827. Wagner-Johnson, Nina [corrected to Wagner-Johnston, Nina].

15.

High prevalence of 1p36 microdeletions in B-cell non-Hodgkin lymphomas (NHL) is associated with PAX7 loss.

Gru AA, Hussaini M, Nguyen T, Frater JL, Kreisel F, Hassan A.

Int J Lab Hematol. 2013 Aug;35(4):e1-5. doi: 10.1111/ijlh.12034. Epub 2012 Dec 4. No abstract available.

PMID:
23205730
16.

Cutaneous myeloid sarcoma: natural history and biology of an uncommon manifestation of acute myeloid leukemia.

Hurley MY, Ghahramani GK, Frisch S, Armbrecht ES, Lind AC, Nguyen TT, Hassan A, Kreisel FH, Frater JL.

Acta Derm Venereol. 2013 May;93(3):319-24. doi: 10.2340/00015555-1458.

17.

Use of a United States-based laboratory as a hematopathology reference center for a developing country: logistics and results.

Deetz CO, Scott MG, Ladenson JH, Seyoum M, Hassan A, Kreisel FH, Nguyen TT, Frater JL.

Int J Lab Hematol. 2013 Feb;35(1):77-81. doi: 10.1111/ijlh.12001. Epub 2012 Sep 3.

PMID:
22938565
18.

Gastrointestinal lymphomas in a North American population: clinicopathologic features from one major Central-Midwestern United States tertiary care medical center.

Warrick J, Luo J, Robirds D, Branson J, Frater JL, Kreisel F, Hassan A, Nguyen TT.

Diagn Pathol. 2012 Jun 28;7:76. doi: 10.1186/1746-1596-7-76.

19.

MIST1-a novel marker of plasmacytic differentiation.

Yeung CC, Mills JC, Hassan A, Kreisel FH, Nguyen TT, Frater JL.

Appl Immunohistochem Mol Morphol. 2012 Dec;20(6):561-5. doi: 10.1097/PAI.0b013e31824e93f2.

PMID:
22495370
20.

Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcoma.

Amador-Ortiz C, Hurley MY, Ghahramani GK, Frisch S, Klco JM, Lind AC, Nguyen TT, Hassan A, Kreisel FH, Frater JL.

J Cutan Pathol. 2011 Dec;38(12):945-53. doi: 10.1111/j.1600-0560.2011.01809.x.

PMID:
22050091
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk